Expression and immunopathogenic mechanism of osteopontin in Graves' disease

綦一澄,李晓丽,王燕燕,章晓芳,黄凤娇,林东平,宁光,王曙
DOI: https://doi.org/10.3760/cma.j.issn.1000-6699.2013.08.011
2013-01-01
Abstract:Objective To investigate the expression of osteopontin(OPN) in Graves' disease(GD),and to study the role played by OPN in modulating CD40 ligand expression.Methods Thirty initial GD patients,twenty-one GD patients during remission,and twenty healthy controls were recruited.Concentrations of OPN and soluble CD40 ligand were determined by ELISA.The expressions of OPN receptor genes in peripheral blood mononuclear cells and CD40 ligand gene in CD4+T cell were determined by real-time quantitative PCR.Results Plasma OPN level in GD patients was significantly higher than that in normal controls[(153 ±55 vs 52±21) ng/ml,P<0.01],while the level in GD patients during remission[(64 ± 19 vs 52 ± 21) ng/ml,P>0.05] showed no significant changes.Compared to healthy controls,soluble CD40 ligand was enhanced in GD patients [(3031 ± 1074 vs 1073 ± 351) pg/ml,P<0.01]and in patients during remission,no significant differences found [(974 ± 273 vs 1073 ± 351) pg/ml,P>0.05].Plasma OPN was correlated with soluble CD40 ligand concentration(r=0.849,P<0.01),while OPN could increase soluble CD40 ligand level and CD40 ligand mRNA expression in CD4+T cells.Conclusions CD40 ligand is induced by increased OPN and serves as the downstream effector of OPN in GD development.
What problem does this paper attempt to address?